Fourth indication approved for gemcitabine

PROMIS scores demonstrated the disparities between reported pain and mental health outcomes.

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

Despite an interest in services, a majority of women do not have these critical conversations with their health care providers.

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

NSAIDS are typically the first line of treatment for axial spondyloarthritis.

On the most recent episode of Over the Counter, James Rider, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.